The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Bibliography: Interventions – Harm Reduction
Health, rights and drugs (PDF)
Harm reduction, decriminalization and zero discrimination for people who use drugs (UNAIDS)
Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to harm reduction services
New report by UNAIDS highlights the urgent need to implement a human rights and evidence-informed approach to reach people who inject drugs with essential health service
Take-home Naloxone in England
Local Authority Survey (Release)
Widening the availability of naloxone
Explains regulations that widen the availability of naloxone, a drug used as an antidote for heroin (or other opiate) overdoses (Public Health England)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
Reformulation of OxyContin to Discourage Abuse Linked to Higher Rates of Hepatitis C Infections
Reformulation of the pain medicine OxyContin in 2010 to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers switched from the prescription medication to injectable heroin, according to a new RAND Corporation study (RAND)
Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, it’s critical that we continue to address this tragedy from all fronts. This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose (FDA)
Prison health inquiry: government response
The government’s response to the Health and Social Care Committee’s inquiry into prison health (Department of Health and Social Care)
m-Health applications for responding to drug use and associated harms
This paper presents results from a scoping study on the availability of smartphone-based applications in the drugs field within a European and global context (EMCDDA)
Canadian Substance Use Costs and Harms in the Provinces and Territories (2007–2014) PDF
In June 2018, the Canadian Substance Use Costs and Harms Scientific Working Group released the results of a significant new study in a comprehensive technical report, Canadian Substance Use Costs and Harms (2007–2014). The report presents estimates of the economic costs and harms of substance use in Canada for the years 2007 to 2014
National intelligence network on drug health harms briefing: December 2018
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (PHE)
Just Maintaining the Status Quo?
The experience of long-term participants in Methadone Maintenance Treatment – PDF (dun Laoghaire rathdown drug and alcohol Task force)
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States
Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member or close friend die from opioids. Increasing the availability and reducing the costs of approved medications for those with an opioid use disorder (OUD) is imperative; however, jurisdictions addressing OUDs and overdose may wish to consider additional interventions. Download (RAND)
Rights, Respect and Recovery (PDF)
Scotland’s strategy to improve health by preventing and reducing alcohol and drug use, harm and related deaths (Scottish Government)
National Naloxone Programme Scotland Monitoring Report 2017/18 (PDF)
A total of 8,397 take-home naloxone kits were issued in Scotland in 2017/18, an increase of 3% from the previous year (NHS National Services Scotland)
Hepatitis C treatment monitoring in England
Preliminary findings from the Hepatitis C patient registry and treatment outcome system (Public Health England)
Canadian Substance Use Costs and Harms in the Provinces and Territories (2007–2014) PDF
The aim of this document is to provide these detailed costs so that researchers, decision makers and others can use them to inform policies and programs at the provincial and territorial levels (CCSA)
Criminal exploitation and ‘county lines’: learn from past mistakes, report finds
Report finds that local agencies must learn lessons from past sexual exploitation cases to respond to ‘county lines’ and other child criminal exploitation (Ofsted, Care Quality Commission, HM Inspectorate of Probation, and HM Inspectorate of Constabulary and Fire & Rescue Services)
Opioid harm in Australia: and comparisons between Australia and Canada
This report shows that opioid harms are an issue in both Australia and Canada. Rates of opioid deaths and opioid poisoning hospitalisations in Australia increased in the last 10 years. In 2016, pharmaceutical opioids were involved in more opioid deaths and opioid poisoning hospitalisations than heroin (AIHW)
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 15
- Next Page »
